Literature DB >> 9027501

Sequence analysis of 497 mouse brain ESTs expressed in the substantia nigra.

G J Stewart1, A Savioz, R W Davies.   

Abstract

The use of subtracted, region-specific cDNA libraries combined with single-pass cDNA sequencing allows the discovery of novel genes and facilitates molecular description of the tissue or region involved. We report the sequence of 497 mouse expressed sequence tags (ESTs) from two subtracted libraries enriched for cDNAs expressed in the substantia nigra, a brain region with important roles in movement control and Parkinson disease. Of these, 238 ESTs give no database matches and therefore derive from novel genes. A further 115 ESTs show sequence similarity to ESTs from other organisms, which themselves do not yield any significant database matches to genes of known function. Fifty-six ESTs show sequence similarity to previously identified genes whose mouse homologues have not been reported. The total number of ESTs reported that are new for the mouse is 407, which, together with the 90 ESTs corresponding to known mouse genes or cDNAs, contributes to the molecular description of the substantia nigra.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9027501     DOI: 10.1006/geno.1996.4503

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  3 in total

1.  Parkinson's disease candidate gene prioritization based on expression profile of midbrain dopaminergic neurons.

Authors:  Shahrooz Vahedi; Mehrnoosh Rajabian; Arman Misaghian; Daniel Grbec; Horst H Simon; Kambiz N Alavian
Journal:  J Biomed Sci       Date:  2010-08-17       Impact factor: 8.410

2.  Merging mouse transcriptome analyses with Parkinson's disease linkage studies.

Authors:  Daniel Gherbassi; Lavinia Bhatt; Sandrine Thuret; Horst H Simon
Journal:  DNA Res       Date:  2007-05-23       Impact factor: 4.458

3.  Linkage of cDNA expression profiles of mesencephalic dopaminergic neurons to a genome-wide in situ hybridization database.

Authors:  Kambiz N Alavian; Horst H Simon
Journal:  Mol Neurodegener       Date:  2009-01-29       Impact factor: 14.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.